CTLA4 and neoplasm: Consistent with these results, the anti-PD-1 and anti-CTLA4 antibodies alone showed a significant tumor growth inhibitory effect compared to the PBS group, and the addition of B. longum 420 to these antibodies significantly enhanced the antitumor activity (Fig. 3b).